Table 2.
Hazard ratio | 95%CI | p value | |
---|---|---|---|
BCLC (intermediate or advanced) | 12.7 | 3.32–84.29 | <0.001 |
Dose of cislatin (mg/body) | 1.01 | 0.99–1.03 | 0.372 |
Treatment without NK1 antagonist | 3.36 | 1.14–10.23 | 0.002 |
Hazard ratio | 95%CI | p value | |
---|---|---|---|
BCLC (intermediate or advanced) | 12.7 | 3.32–84.29 | <0.001 |
Dose of cislatin (mg/body) | 1.01 | 0.99–1.03 | 0.372 |
Treatment without NK1 antagonist | 3.36 | 1.14–10.23 | 0.002 |